Clinical Trial Update: Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers [NA]

View source ↗

Summary

This completed clinical trial study characterizes how daily 4.5 g/day chitin-glucan fibre for 3 weeks influences gut microbiota composition and activity in indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Obesity
• Metabolic Syndrome

Drugs mentioned

• ChitinGlucan Fibre (chitin-glucan fibre)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cardiometabolic Risk, Abdominal Obesity | NA | Status: COMPLETED